Listed

Modular Medical, Inc.

MODDNasdaqCIK 1074871HealthcareFiscal year ends Mar 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$6.5m, Q1 FY2027
Net income−$6.5m, Q1 FY2027
Modular Medical, Inc., income statement, quarterly
Line itemUnitQ2 FY20242023-09-30Q3 FY20242023-12-31Q4 FY20242024-03-31Q1 FY20252024-06-30Q2 FY20252024-09-30Q3 FY20252024-12-31Q4 FY20252025-03-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31Q4 FY20262026-03-31Q1 FY20272026-06-30
Revenue$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Cost of revenue$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Gross profit$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$k3,159Research and development, Q2 FY2024, three months to 2023-09-30$3.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001213900-24-098418.Report this figure3,838Research and development, Q3 FY2024, three months to 2023-12-31$3.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-02-13, accession 0001213900-25-013462.Report this figure3,115Research and development, Q4 FY2024, three months to 2024-03-31$3.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-06-20, accession 0001213900-25-055793. Derived: 12-month figure less the 9-month figure.Report this figure3,205Research and development, Q1 FY2025, three months to 2024-06-30$3.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001213900-25-076594.Report this figure3,702Research and development, Q2 FY2025, three months to 2024-09-30$3.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001213900-25-110819.Report this figure3,853Research and development, Q3 FY2025, three months to 2024-12-31$3.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figure3,937Research and development, Q4 FY2025, three months to 2025-03-31$3.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-06-29, accession 0001213900-26-073223. Derived: 12-month figure less the 9-month figure.Report this figure5,134Research and development, Q1 FY2026, three months to 2025-06-30$5.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure5,593Research and development, Q2 FY2026, three months to 2025-09-30$5.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001213900-25-110819.Report this figure5,405Research and development, Q3 FY2026, three months to 2025-12-31$5.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figure3,841Research and development, Q4 FY2026, three months to 2026-03-31$3.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-06-29, accession 0001213900-26-073223. Derived: 12-month figure less the 9-month figure.Report this figure4,371Research and development, Q1 FY2027, three months to 2026-06-30$4.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure
Operating income$k(4,190)Operating income, Q2 FY2024, three months to 2023-09-30−$4.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001213900-24-098418.Report this figure(5,269)Operating income, Q3 FY2024, three months to 2023-12-31−$5.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-02-13, accession 0001213900-25-013462.Report this figure(4,319)Operating income, Q4 FY2024, three months to 2024-03-31−$4.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-06-20, accession 0001213900-25-055793. Derived: 12-month figure less the 9-month figure.Report this figure(4,220)Operating income, Q1 FY2025, three months to 2024-06-30−$4.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001213900-25-076594.Report this figure(4,996)Operating income, Q2 FY2025, three months to 2024-09-30−$5.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001213900-25-110819.Report this figure(4,854)Operating income, Q3 FY2025, three months to 2024-12-31−$4.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figure(4,978)Operating income, Q4 FY2025, three months to 2025-03-31−$5.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-06-29, accession 0001213900-26-073223. Derived: 12-month figure less the 9-month figure.Report this figure(6,804)Operating income, Q1 FY2026, three months to 2025-06-30−$6.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure(7,829)Operating income, Q2 FY2026, three months to 2025-09-30−$7.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001213900-25-110819.Report this figure(7,244)Operating income, Q3 FY2026, three months to 2025-12-31−$7.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figure(5,683)Operating income, Q4 FY2026, three months to 2026-03-31−$5.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-06-29, accession 0001213900-26-073223. Derived: 12-month figure less the 9-month figure.Report this figure(6,538)Operating income, Q1 FY2027, three months to 2026-06-30−$6.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure
Interest expense$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$k2.0Income tax, Q2 FY2024, three months to 2023-09-30$2.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-14, accession 0001213900-24-098418.Report this figure0.0Income tax, Q3 FY2024, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-02-13, accession 0001213900-25-013462. Derived: 9-month figure less the 6-month figure.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-06-20, accession 0001213900-25-055793. Derived: 12-month figure less the 9-month figure.Report this figurenot reported2.0Income tax, Q2 FY2025, three months to 2024-09-30$2.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-14, accession 0001213900-25-110819.Report this figure0.0Income tax, Q3 FY2025, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-02-17, accession 0001213900-26-017262. Derived: 9-month figure less the 6-month figure.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-06-29, accession 0001213900-26-073223. Derived: 12-month figure less the 9-month figure.Report this figurenot reported2.0Income tax, Q2 FY2026, three months to 2025-09-30$2.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-14, accession 0001213900-25-110819.Report this figure0.0Income tax, Q3 FY2026, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-02-17, accession 0001213900-26-017262. Derived: 9-month figure less the 6-month figure.Report this figure0.0Income tax, Q4 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-06-29, accession 0001213900-26-073223. Derived: 12-month figure less the 9-month figure.Report this figurenot reported
Net income$k(4,183)Net income, Q2 FY2024, three months to 2023-09-30−$4.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-02-13, accession 0001213900-25-013462.Report this figure(5,269)Net income, Q3 FY2024, three months to 2023-12-31−$5.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-02-13, accession 0001213900-25-013462.Report this figure(4,281)Net income, Q4 FY2024, three months to 2024-03-31−$4.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-06-20, accession 0001213900-25-055793. Derived: 12-month figure less the 9-month figure.Report this figure(4,137)Net income, Q1 FY2025, three months to 2024-06-30−$4.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figure(4,956)Net income, Q2 FY2025, three months to 2024-09-30−$5.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figure(4,804)Net income, Q3 FY2025, three months to 2024-12-31−$4.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figure(4,927)Net income, Q4 FY2025, three months to 2025-03-31−$4.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-06-29, accession 0001213900-26-073223. Derived: 12-month figure less the 9-month figure.Report this figure(6,702)Net income, Q1 FY2026, three months to 2025-06-30−$6.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure(7,790)Net income, Q2 FY2026, three months to 2025-09-30−$7.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figure(7,360)Net income, Q3 FY2026, three months to 2025-12-31−$7.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figure(6,390)Net income, Q4 FY2026, three months to 2026-03-31−$6.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-06-29, accession 0001213900-26-073223. Derived: 12-month figure less the 9-month figure.Report this figure(6,486)Net income, Q1 FY2027, three months to 2026-06-30−$6.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure
Diluted EPS$ per share(0.19)Diluted EPS, Q2 FY2024, three months to 2023-09-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001213900-24-098418.Report this figure(0.23)Diluted EPS, Q3 FY2024, three months to 2023-12-31−$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-02-13, accession 0001213900-25-013462.Report this figurenot reported(0.12)Diluted EPS, Q1 FY2025, three months to 2024-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001213900-25-076594.Report this figure(0.14)Diluted EPS, Q2 FY2025, three months to 2024-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001213900-25-110819.Report this figure(0.13)Diluted EPS, Q3 FY2025, three months to 2024-12-31−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figurenot reported(3.70)Diluted EPS, Q1 FY2026, three months to 2025-06-30−$3.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure(0.14)Diluted EPS, Q2 FY2026, three months to 2025-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001213900-25-110819.Report this figure(0.11)Diluted EPS, Q3 FY2026, three months to 2025-12-31−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figurenot reported(1.19)Diluted EPS, Q1 FY2027, three months to 2026-06-30−$1.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure
Basic EPS$ per share(0.19)Basic EPS, Q2 FY2024, three months to 2023-09-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001213900-24-098418.Report this figure(0.23)Basic EPS, Q3 FY2024, three months to 2023-12-31−$0.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-02-13, accession 0001213900-25-013462.Report this figurenot reported(0.12)Basic EPS, Q1 FY2025, three months to 2024-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001213900-25-076594.Report this figure(0.14)Basic EPS, Q2 FY2025, three months to 2024-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001213900-25-110819.Report this figure(0.13)Basic EPS, Q3 FY2025, three months to 2024-12-31−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figurenot reported(3.70)Basic EPS, Q1 FY2026, three months to 2025-06-30−$3.70 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure(0.14)Basic EPS, Q2 FY2026, three months to 2025-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001213900-25-110819.Report this figure(0.11)Basic EPS, Q3 FY2026, three months to 2025-12-31−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figurenot reported(1.19)Basic EPS, Q1 FY2027, three months to 2026-06-30−$1.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure

Balance sheet

Cash and equivalents$3.9m, Q1 FY2027
Shareholders' equity$10.8m, Q1 FY2027
Modular Medical, Inc., balance sheet, quarterly
Line itemUnitQ2 FY20242023-09-30Q3 FY20242023-12-31FY20242024-03-31Q1 FY20252024-06-30Q2 FY20252024-09-30Q3 FY20252024-12-31FY20252025-03-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31FY20262026-03-31Q1 FY20272026-06-30
Cash and equivalents$m6.3Cash and equivalents, Q2 FY2024, at 2023-09-30$6.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0001213900-23-086248.Report this figure2.0Cash and equivalents, Q3 FY2024, at 2023-12-31$2.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-02-13, accession 0001213900-24-013348.Report this figure9.2Cash and equivalents, FY2024, at 2024-03-31$9.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-06-20, accession 0001213900-25-055793.Report this figurenot reportednot reported7.0Cash and equivalents, Q3 FY2025, at 2024-12-31$7.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-02-13, accession 0001213900-25-013462.Report this figure13.1Cash and equivalents, FY2025, at 2025-03-31$13.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-06-29, accession 0001213900-26-073223.Report this figure7.5Cash and equivalents, Q1 FY2026, at 2025-06-30$7.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0001213900-25-076594.Report this figure5.3Cash and equivalents, Q2 FY2026, at 2025-09-30$5.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-14, accession 0001213900-25-110819.Report this figure2.9Cash and equivalents, Q3 FY2026, at 2025-12-31$2.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figure6.9Cash and equivalents, FY2026, at 2026-03-31$6.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure3.9Cash and equivalents, Q1 FY2027, at 2026-06-30$3.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure
Current assets$m6.5Current assets, Q2 FY2024, at 2023-09-30$6.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001213900-23-086248.Report this figure2.3Current assets, Q3 FY2024, at 2023-12-31$2.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-02-13, accession 0001213900-24-013348.Report this figure9.7Current assets, FY2024, at 2024-03-31$9.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-06-20, accession 0001213900-25-055793.Report this figure5.4Current assets, Q1 FY2025, at 2024-06-30$5.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0001213900-24-068407.Report this figure4.2Current assets, Q2 FY2025, at 2024-09-30$4.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001213900-24-098418.Report this figure7.3Current assets, Q3 FY2025, at 2024-12-31$7.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-02-13, accession 0001213900-25-013462.Report this figure13.5Current assets, FY2025, at 2025-03-31$13.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-06-29, accession 0001213900-26-073223.Report this figure8.3Current assets, Q1 FY2026, at 2025-06-30$8.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001213900-25-076594.Report this figure5.9Current assets, Q2 FY2026, at 2025-09-30$5.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-14, accession 0001213900-25-110819.Report this figure3.5Current assets, Q3 FY2026, at 2025-12-31$3.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figure7.5Current assets, FY2026, at 2026-03-31$7.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure4.8Current assets, Q1 FY2027, at 2026-06-30$4.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure
Total assets$m10.1Total assets, Q2 FY2024, at 2023-09-30$10.1m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001213900-23-086248.Report this figure6.2Total assets, Q3 FY2024, at 2023-12-31$6.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-02-13, accession 0001213900-24-013348.Report this figure13.8Total assets, FY2024, at 2024-03-31$13.8m. XBRL concept us-gaap:Assets. 10-K filed 2025-06-20, accession 0001213900-25-055793.Report this figure10.1Total assets, Q1 FY2025, at 2024-06-30$10.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0001213900-24-068407.Report this figure8.8Total assets, Q2 FY2025, at 2024-09-30$8.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001213900-24-098418.Report this figure12.1Total assets, Q3 FY2025, at 2024-12-31$12.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-02-13, accession 0001213900-25-013462.Report this figure18.7Total assets, FY2025, at 2025-03-31$18.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-06-29, accession 0001213900-26-073223.Report this figure14.2Total assets, Q1 FY2026, at 2025-06-30$14.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001213900-25-076594.Report this figure13.0Total assets, Q2 FY2026, at 2025-09-30$13.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-14, accession 0001213900-25-110819.Report this figure10.3Total assets, Q3 FY2026, at 2025-12-31$10.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figure14.8Total assets, FY2026, at 2026-03-31$14.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure12.3Total assets, Q1 FY2027, at 2026-06-30$12.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure
Current liabilities$m1.1Current liabilities, Q2 FY2024, at 2023-09-30$1.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001213900-23-086248.Report this figure1.4Current liabilities, Q3 FY2024, at 2023-12-31$1.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-02-13, accession 0001213900-24-013348.Report this figure1.5Current liabilities, FY2024, at 2024-03-31$1.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-06-20, accession 0001213900-25-055793.Report this figure1.3Current liabilities, Q1 FY2025, at 2024-06-30$1.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0001213900-24-068407.Report this figure1.2Current liabilities, Q2 FY2025, at 2024-09-30$1.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001213900-24-098418.Report this figure1.4Current liabilities, Q3 FY2025, at 2024-12-31$1.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-02-13, accession 0001213900-25-013462.Report this figure1.3Current liabilities, FY2025, at 2025-03-31$1.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-06-29, accession 0001213900-26-073223.Report this figure2.1Current liabilities, Q1 FY2026, at 2025-06-30$2.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001213900-25-076594.Report this figure4.0Current liabilities, Q2 FY2026, at 2025-09-30$4.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-14, accession 0001213900-25-110819.Report this figure2.2Current liabilities, Q3 FY2026, at 2025-12-31$2.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figure1.9Current liabilities, FY2026, at 2026-03-31$1.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure1.5Current liabilities, Q1 FY2027, at 2026-06-30$1.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure
Total liabilities$m2.1Total liabilities, Q2 FY2024, at 2023-09-30$2.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001213900-23-086248.Report this figure2.4Total liabilities, Q3 FY2024, at 2023-12-31$2.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-02-13, accession 0001213900-24-013348.Report this figure2.3Total liabilities, FY2024, at 2024-03-31$2.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-06-20, accession 0001213900-25-055793.Report this figure2.1Total liabilities, Q1 FY2025, at 2024-06-30$2.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0001213900-24-068407.Report this figure1.9Total liabilities, Q2 FY2025, at 2024-09-30$1.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001213900-24-098418.Report this figure1.9Total liabilities, Q3 FY2025, at 2024-12-31$1.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-02-13, accession 0001213900-25-013462.Report this figure1.7Total liabilities, FY2025, at 2025-03-31$1.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-06-29, accession 0001213900-26-073223.Report this figure2.3Total liabilities, Q1 FY2026, at 2025-06-30$2.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001213900-25-076594.Report this figure4.2Total liabilities, Q2 FY2026, at 2025-09-30$4.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-14, accession 0001213900-25-110819.Report this figure4.4Total liabilities, Q3 FY2026, at 2025-12-31$4.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figure1.9Total liabilities, FY2026, at 2026-03-31$1.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure1.5Total liabilities, Q1 FY2027, at 2026-06-30$1.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure
Shareholders' equity$m7.9Shareholders' equity, Q2 FY2024, at 2023-09-30$7.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-02-13, accession 0001213900-25-013462.Report this figure3.8Shareholders' equity, Q3 FY2024, at 2023-12-31$3.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-02-13, accession 0001213900-25-013462.Report this figure11.5Shareholders' equity, FY2024, at 2024-03-31$11.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-06-29, accession 0001213900-26-073223.Report this figure8.0Shareholders' equity, Q1 FY2025, at 2024-06-30$8.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figure6.9Shareholders' equity, Q2 FY2025, at 2024-09-30$6.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figure10.3Shareholders' equity, Q3 FY2025, at 2024-12-31$10.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figure17.1Shareholders' equity, FY2025, at 2025-03-31$17.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure11.8Shareholders' equity, Q1 FY2026, at 2025-06-30$11.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure8.8Shareholders' equity, Q2 FY2026, at 2025-09-30$8.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figure5.9Shareholders' equity, Q3 FY2026, at 2025-12-31$5.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figure13.0Shareholders' equity, FY2026, at 2026-03-31$13.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure10.8Shareholders' equity, Q1 FY2027, at 2026-06-30$10.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure

Cash flow

Operating cash flow−$6.0m, Q1 FY2027
Capital expenditure$688.0k, Q1 FY2027
Modular Medical, Inc., cash flow, quarterly
Line itemUnitQ2 FY20242023-09-30Q3 FY20242023-12-31Q4 FY20242024-03-31Q1 FY20252024-06-30Q2 FY20252024-09-30Q3 FY20252024-12-31Q4 FY20252025-03-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31Q4 FY20262026-03-31Q1 FY20272026-06-30
Operating cash flow$k(3,277)Operating cash flow, Q2 FY2024, three months to 2023-09-30−$3.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001213900-24-098418. Derived: 6-month figure less the 3-month figure.Report this figure(3,965)Operating cash flow, Q3 FY2024, three months to 2023-12-31−$4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-02-13, accession 0001213900-25-013462. Derived: 9-month figure less the 6-month figure.Report this figure(3,503)Operating cash flow, Q4 FY2024, three months to 2024-03-31−$3.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-06-20, accession 0001213900-25-055793. Derived: 12-month figure less the 9-month figure.Report this figure(3,548)Operating cash flow, Q1 FY2025, three months to 2024-06-30−$3.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001213900-25-076594.Report this figure(3,766)Operating cash flow, Q2 FY2025, three months to 2024-09-30−$3.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001213900-25-110819. Derived: 6-month figure less the 3-month figure.Report this figure(4,096)Operating cash flow, Q3 FY2025, three months to 2024-12-31−$4.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-17, accession 0001213900-26-017262. Derived: 9-month figure less the 6-month figure.Report this figure(4,310)Operating cash flow, Q4 FY2025, three months to 2025-03-31−$4.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-29, accession 0001213900-26-073223. Derived: 12-month figure less the 9-month figure.Report this figure(5,372)Operating cash flow, Q1 FY2026, three months to 2025-06-30−$5.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure(5,411)Operating cash flow, Q2 FY2026, three months to 2025-09-30−$5.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001213900-25-110819. Derived: 6-month figure less the 3-month figure.Report this figure(7,155)Operating cash flow, Q3 FY2026, three months to 2025-12-31−$7.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-17, accession 0001213900-26-017262. Derived: 9-month figure less the 6-month figure.Report this figure(5,815)Operating cash flow, Q4 FY2026, three months to 2026-03-31−$5.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-29, accession 0001213900-26-073223. Derived: 12-month figure less the 9-month figure.Report this figure(5,972)Operating cash flow, Q1 FY2027, three months to 2026-06-30−$6.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure
Capital expenditure$k345Capital expenditure, Q2 FY2024, three months to 2023-09-30$345.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0001213900-24-098418. Derived: 6-month figure less the 3-month figure.Report this figure499Capital expenditure, Q3 FY2024, three months to 2023-12-31$499.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-02-13, accession 0001213900-25-013462. Derived: 9-month figure less the 6-month figure.Report this figure483Capital expenditure, Q4 FY2024, three months to 2024-03-31$483.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-06-20, accession 0001213900-25-055793. Derived: 12-month figure less the 9-month figure.Report this figure842Capital expenditure, Q1 FY2025, three months to 2024-06-30$842.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-14, accession 0001213900-25-076594.Report this figure161Capital expenditure, Q2 FY2025, three months to 2024-09-30$161.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0001213900-25-110819. Derived: 6-month figure less the 3-month figure.Report this figure542Capital expenditure, Q3 FY2025, three months to 2024-12-31$542.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-17, accession 0001213900-26-017262. Derived: 9-month figure less the 6-month figure.Report this figure948Capital expenditure, Q4 FY2025, three months to 2025-03-31$948.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-06-29, accession 0001213900-26-073223. Derived: 12-month figure less the 9-month figure.Report this figure934Capital expenditure, Q1 FY2026, three months to 2025-06-30$934.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure771Capital expenditure, Q2 FY2026, three months to 2025-09-30$771.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0001213900-25-110819. Derived: 6-month figure less the 3-month figure.Report this figure1,222Capital expenditure, Q3 FY2026, three months to 2025-12-31$1.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-17, accession 0001213900-26-017262. Derived: 9-month figure less the 6-month figure.Report this figure1,005Capital expenditure, Q4 FY2026, three months to 2026-03-31$1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-06-29, accession 0001213900-26-073223. Derived: 12-month figure less the 9-month figure.Report this figure688Capital expenditure, Q1 FY2027, three months to 2026-06-30$688.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure
Share repurchases$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)5.45m, Q1 FY2027
Modular Medical, Inc., shares, quarterly
Line itemUnitQ2 FY20232022-09-30Q3 FY20232022-12-31Q1 FY20242023-06-30Q2 FY20242023-09-30Q3 FY20242023-12-31Q1 FY20252024-06-30Q2 FY20252024-09-30Q3 FY20252024-12-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31Q1 FY20272026-06-30
Diluted shares (weighted)m shares12.3Diluted shares (weighted), Q2 FY2023, three months to 2022-09-3012,263,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0001213900-23-086248.Report this figure12.3Diluted shares (weighted), Q3 FY2023, three months to 2022-12-3112,274,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-02-13, accession 0001213900-24-013348.Report this figure17.1Diluted shares (weighted), Q1 FY2024, three months to 2023-06-3017,099,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0001213900-24-068407.Report this figure22.4Diluted shares (weighted), Q2 FY2024, three months to 2023-09-3022,445,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001213900-24-098418.Report this figure22.5Diluted shares (weighted), Q3 FY2024, three months to 2023-12-3122,540,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-02-13, accession 0001213900-25-013462.Report this figure33.9Diluted shares (weighted), Q1 FY2025, three months to 2024-06-3033,884,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0001213900-25-076594.Report this figure34.3Diluted shares (weighted), Q2 FY2025, three months to 2024-09-3034,338,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001213900-25-110819.Report this figure37.8Diluted shares (weighted), Q3 FY2025, three months to 2024-12-3137,807,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figure1.8Diluted shares (weighted), Q1 FY2026, three months to 2025-06-301,810,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure55.6Diluted shares (weighted), Q2 FY2026, three months to 2025-09-3055,576,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001213900-25-110819.Report this figure65.9Diluted shares (weighted), Q3 FY2026, three months to 2025-12-3165,930,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figure5.5Diluted shares (weighted), Q1 FY2027, three months to 2026-06-305,452,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure

Shares outstanding: 8.15mShares outstanding, period not labelled, at 2026-08-148,150,823 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure at Aug 14, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. Listed shows no prices and gives no investment advice.